SUBSCRIBE
SUBSCRIBE
News   Business

Biogen Idec, Inc. (Massachusetts) Reports Second Quarter 2007 Results

July 24, 2007 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today reported its second quarter 2007 results.
Earnings
Biogen
MORE ON THIS TOPIC
Illustration with office chair concept with many chairs knocked over
Layoffs
TScan cuts 75% of workforce while shifting focus to solid tumor program
September 3, 2026
 · 
2 min read
 · 
Angela Gabriel
Funds help overcome the financial crisis. Business team crossing banknote bridge vector
Funding
US to grant up to $125M for personalized RNA manufacturing innovation
September 3, 2026
 · 
2 min read
 · 
Michael Gibney
Trustworthy and honesty to believe in work together, integrity or trust for partnership, support and reliable to help success together concept, businessman acrobat hold hand tight by trusted partner.
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
 · 
1 min read
 · 
Tristan Manalac
FDA
Novartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
September 2, 2026
 · 
2 min read
 · 
Jef Akst